Approval · Notice of Compliance 1240 · 2000
LEVAQUIN: Notice of Compliance 1240
Issued December 21, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1240
- Date
- December 21, 2000
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for a change in finished product specification
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVAQUIN | Not yet assigned | — |
Medicinal ingredients
- LEVOFLOXACIN 5 MG per ML